Restara Medical, Inc. — SEC Form D Filing
Restara Medical, Inc. filed an SEC Form D on September 23, 2026, reporting $500K raised in Medical Devices.
Form D filing details
- Filing
- SEC Form D
- Filing date
- September 23, 2026
- Amount reported
- $500K
- Industry
- Medical Devices
- Website
- https://www.restoramedical.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Sleep Apnea is a condition that requires therapy.
Solution
Restora Medical provides a therapy for sleep apnea using targeted nerve stimulation.
Verdict
This pre-seed round cleared because it presented a tangible, device-based approach to a well-understood chronic condition, not because it articulated a novel market entry strategy or clear economic advantage. Investors were implicitly betting on the company’s ability to navigate clinical trials and regulatory pathways for a known medical problem, assuming a future reimbursement landscape would emerge. The upside was limited by the significant capital and time required for medical device development, suggesting this was an early de-risking bet rather than a high-growth speculation.
Source: SEC EDGAR Form D filing